Pharma Equity Group A/S

Pharma Equity Group A/S FCF Margin

The Free Cash Flow Margin of Pharma Equity Group A/S (PEG.CO) as of Oct 11, 2026 is -17.17 %. In the previous year, Free Cash Flow Margin was -473.87 % — a change of -96.38% (higher).

FCF Margin

-17.17 %

YoY

-96.38%

Last updated:

Free Cash Flow Margin of Pharma Equity Group A/S is 2016 -17.17 % . Free Cash Flow Margin of Pharma Equity Group A/S was 2015 -473.87 % . It decreases by -96.38% higher compared to the previous year.

The Pharma Equity Group A/S FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2014
-3,636.36 DKK
Jan 1, 2015
-473.87 DKK
Jan 1, 2016
-17.17 DKK
The Pharma Equity Group A/S FCF Margin history
YEARFCF MarginYoY
-17.17 %-96.38%
-473.87 %-86.97%
-3,636.36 %—
Access this data via the Eulerpool API
Get Free API Key

Pharma Equity Group A/S Stock analysis

What does Pharma Equity Group A/S do? Blue Vision A/S is a company specializing in the development, production, and marketing of underwater technology. It was founded in 1992 and is headquartered in Holstebro, Denmark. The company focuses on underwater lighting, underwater inspection cameras, and underwater communication. It specializes in manufacturing underwater lighting products for the offshore industry, ports, and shipping. It also produces underwater inspection cameras for inspecting underwater structures without the need for divers. In addition, the company has developed devices for underwater communication, which are crucial in the offshore industry and military sector. Blue Vision A/S emphasizes innovation and technology, holding patents and investing in digital technology to improve inspection systems. In summary, Blue Vision A/S specializes in underwater technology and offers solutions for the offshore industry, ports, and shipping. The company is committed to innovation and technology to provide the best solutions to its customers. Pharma Equity Group A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharma Equity Group A/S stock

Free Cash Flow Margin of Pharma Equity Group A/S is -17.17 % in 2016.

Free Cash Flow Margin of Pharma Equity Group A/S changed from -473.87 % to -17.17 %, representing a -96.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Pharma Equity Group A/S since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Pharma Equity Group A/S with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API
Get Free API Key

Margins — Pharma Equity Group A/S

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Pharma Equity Group A/S